Ldx.Ax
LDX.AX operates in the healthcare services and equipment sector, providing medical equipment, supplies, and distribution services.
Business. LDX.AX operates in the healthcare services and equipment sector, providing medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
LDX.AX operates in the healthcare services and equipment sector, providing medical equipment, supplies, and distribution services.
The company's capital structure is marked by a debt-to-equity ratio of 1.13, indicating a moderate reliance on debt financing. Liquidity is constrained, with a current ratio of 0.74, suggesting the company may struggle to meet short-term obligations without external financing. The company holds $1.96 million in cash and equivalents, but this is insufficient to cover its $6.99 million in long-term debt, resulting in a negative net cash position.
Profitability is a significant concern, with a return on equity of -1.1666 and a return on assets of -0.3451, both well below industry norms. The company reported a net loss of $7.18 million and an operating loss of $6.55 million, indicating operational inefficiencies and cost overruns. Gross profit of $7.81 million is insufficient to cover operating expenses, highlighting the need for cost restructuring or revenue diversification.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific risks and limits growth opportunities. The absence of segment or geographic breakdowns in the financial data suggests a lack of transparency in operational performance.
Growth trajectory is negative, with a reported revenue of $12.4 million, below the analyst estimate of $16.04 million. The company's operating cash flow of -$9.33 million and free cash flow of -$4.71 million indicate a cash burn rate that could limit reinvestment and expansion. Capital expenditures of -$53,000 suggest minimal investment in long-term growth.
Risk factors include liquidity constraints and a negative net cash position, which could necessitate additional financing or asset sales. Dilution risk is currently low, but the company's negative equity and high debt levels could increase pressure for equity issuance in the future. The risk assessment highlights the need for improved cash flow management and debt restructuring.
Recent events include a reported net loss and operating loss, with no disclosed material filings or transcripts indicating strategic changes or operational improvements. The absence of recent positive developments suggests ongoing challenges in the company's core operations.
- The company is operating at a loss with negative returns on equity and assets.
- Liquidity is constrained, with a current ratio below 1 and insufficient cash to cover long-term debt.
- Revenue is concentrated in a single segment, increasing exposure to sector-specific risks.
- Growth is negative, with cash flow and capital expenditure figures indicating limited reinvestment.
- Risk factors include liquidity constraints and potential future dilution.
- Recent financial performance shows no signs of operational improvement.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- LDX.AX Market data — financials · 2026-05-28
- Lumos Diagnostics Holdings Ltd Market data — analyst estimates · 2026-05-28
Ownership & reference
Leadership
- Samuel LanyonExecutive Chairman of the Board